As dendritic cells increasingly become the adjuvant ... exposure of the tumor to the host immune system. Recurring tumor lesions are selected tumor variants, which display a variety of immune ...

“Those cells are very difficult to capture within an inflammatory lesion,” says Merad. To distinguish different subsets of dendritic cells, Merad and colleagues required more than single-cell ...

The Menarini Group, along with its subsidiary Stemline Therapeutics, has announced a partnership with VisualDx to enhance the ...

The Group ("Menarini"), a leading international pharmaceutical and diagnostics company, and Stemline Therapeutics, Inc.